CFRX has been the subject of several other reports. Maxim Group reiterated a hold rating on shares of ContraFect Corp. in a research note on Tuesday, August 9th. Piper Jaffray Cos. assumed coverage on shares of ContraFect Corp. in a research report on Thursday, July 28th. They set an overweight rating for the company.
Shares of ContraFect Corp. (NASDAQ:CFRX) opened at 2.48 on Wednesday. The stock has a 50 day moving average of $2.39 and a 200 day moving average of $2.87. ContraFect Corp. has a 12-month low of $2.10 and a 12-month high of $5.35. The company’s market cap is $103.02 million.
ContraFect Corp. (NASDAQ:CFRX) last posted its earnings results on Tuesday, August 9th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by $0.08. Equities research analysts predict that ContraFect Corp. will post ($1.01) earnings per share for the current fiscal year.
In related news, CEO Steven C. Gilman acquired 20,000 shares of ContraFect Corp. stock in a transaction on Wednesday, July 27th. The stock was bought at an average cost of $2.48 per share, for a total transaction of $49,600.00. Following the completion of the transaction, the chief executive officer now owns 20,000 shares of the company’s stock, valued at approximately $49,600. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 15.00% of the company’s stock.
A number of institutional investors have recently bought and sold shares of CFRX. BlackRock Fund Advisors boosted its position in ContraFect Corp. by 41.9% in the second quarter. BlackRock Fund Advisors now owns 57,923 shares of the company’s stock worth $167,000 after buying an additional 17,092 shares in the last quarter. Sunbelt Securities Inc. acquired a new stake in ContraFect Corp. during the second quarter worth about $578,000. Adage Capital Partners GP L.L.C. raised its stake in ContraFect Corp. by 50.0% in the first quarter. Adage Capital Partners GP L.L.C. now owns 1,500,000 shares of the company’s stock worth $5,100,000 after buying an additional 500,000 shares during the last quarter. Finally, Cormorant Asset Management LLC raised its stake in ContraFect Corp. by 256.0% in the first quarter. Cormorant Asset Management LLC now owns 834,406 shares of the company’s stock worth $2,837,000 after buying an additional 600,000 shares during the last quarter. Institutional investors own 13.55% of the company’s stock.
Receive News & Ratings for ContraFect Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ContraFect Corp. and related companies with MarketBeat.com's FREE daily email newsletter.